** Shares of Somnomed SOM.AX rise as much as 18.9% to A$0.785, their biggest intraday pct jump since late July 2025

** Shares of the treatment provider for disorders such as sleep apnea climb to their highest level since December 23

** Company posts record half-year revenue of A$60.7 million ($43.21 million)

** Half-year EBITDA rises 35% to A$7.8 million

** Stock down 5.5% this year, including the day's move

($1 = 1.4047 Australian dollars)

(Reporting by John Biju in Bengaluru)

((John.Biju@thomsonreuters.com;))